Complete Filing Data
Calidi Biotherapeutics, Inc. reported Net Income Loss of -$19.91 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Calidi Biotherapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$19.9M | -$22.1M | -$29.2M | -$25.4M |
| Operating Income Loss | -$20.2M | -$21.8M | -$29.0M | -$23.1M |
| Nonoperating Income Expense | $192.0K | -$419.0K | -$208.0K | -$2.3M |
| Operating Expenses | $20.2M | $21.8M | $29.0M | $23.2M |
| Income Tax Expense Benefit | $15.0K | $14.0K | $16.0K | $11.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$20.0M | -$22.2M | -$29.2M | -$25.4M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $15.0K | $19.0K | -$33.0K | -$13.0K |
| Research And Development Expense | $9.7M | $8.9M | $13.0M | $7.3M |
| Other Nonoperating Income Expense | $103.0K | $9.0K | -$51.0K | -$5.0K |
| Comprehensive Income Net Of Tax | -$19.9M | -$22.1M | -$29.2M | -$25.4M |
| Selling General And Administrative Expense | $10.5M | $12.9M | $16.0M | $15.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $15.0K | $19.0K | -$33.0K | |
| Net Income Loss Available To Common Stockholders Basic | -$25.6M | -$23.8M | -$29.2M | |
| Income Taxes Paid | $11.0K | $11.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$20.0M | -$22.2M | -$29.2M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $45.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$5.1M | -$5.7M | -$5.1M | -$5.1M | -$5.8M | -$7.2M | -$2.0M | -$12.5M | -$6.5M | -$5.4M | -$4.6M | -$7.7M | -$823.3K | -$83.3K | $0.00 |
| Operating Income Loss | -$5.0M | -$5.7M | -$5.1M | -$5.2M | -$5.8M | -$6.8M | -$7.2M | -$6.5M | -$5.4M | -$7.0M | -$361.6K | -$528.9K | -$1.1M | -$83.3K | |
| Nonoperating Income Expense | -$123.0K | -$93.0K | $3.0K | $156.0K | $13.0K | -$469.0K | $5.2M | -$6.0M | -$1.0M | $1.6M | $4.5M | $2.0M | $271.6K | $0.00 | |
| Operating Expenses | $5.0M | $5.7M | $5.1M | $5.2M | $5.8M | $6.8M | $7.2M | $6.5M | $5.4M | $7.0M | $361.6K | $528.9K | $1.1M | $83.3K | |
| Income Tax Expense Benefit | $10.0K | $4.0K | $3.0K | -$1.0K | $8.0K | $4.0K | $11.0K | $4.0K | $4.0K | $1.0K | $0.00 | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.2M | -$5.8M | -$5.1M | -$5.1M | -$5.8M | -$7.2M | -$2.0M | -$12.5M | -$6.5M | -$5.4M | $4.2M | $1.5M | -$823.3K | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $13.0K | $2.0K | -$47.0K | -$38.0K | $58.0K | $13.0K | -$5.0K | $2.0K | -$13.0K | -$11.0K | -$6.0K | ||||
| Research And Development Expense | $2.4M | $2.6M | $2.4M | $2.2M | $2.2M | $2.7M | $3.3M | $3.2M | $2.6M | $1.9M | |||||
| Other Nonoperating Income Expense | $18.0K | -$22.0K | -$10.0K | $8.0K | $10.0K | -$17.0K | -$8.0K | -$16.0K | -$5.0K | $4.0K | |||||
| Comprehensive Income Net Of Tax | -$5.1M | -$5.7M | -$5.0M | -$5.1M | -$5.8M | -$7.2M | -$2.0M | -$12.5M | -$6.5M | -$5.4M | |||||
| Selling General And Administrative Expense | $2.7M | $3.1M | $2.6M | $3.1M | $3.6M | $4.0M | $4.0M | $3.4M | $2.8M | $5.0M | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $13.0K | $2.0K | -$47.0K | -$38.0K | $58.0K | $13.0K | -$5.0K | ||||||||
| Net Income Loss Available To Common Stockholders Basic | -$10.8M | -$5.7M | -$5.0M | -$5.1M | -$7.4M | -$7.2M | -$2.0M | -$12.5M | |||||||
| Income Taxes Paid | |||||||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$5.2M | -$5.7M | -$5.1M | -$5.1M | -$5.8M | -$7.2M | -$2.0M | ||||||||
| Revenue From Contract With Customer Excluding Assessed Tax |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $3.8M | $1.5M | -$8.2M | -$50.4M | -$31.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.8M | $9.8M | $2.2M | $590.0K | $2.2M |
| Cash | $1.1M | ||||
| Retained Earnings Accumulated Deficit | -$141.6M | -$121.7M | -$99.6M | -$70.4M | -$14.7M |
| Liabilities Current | $3.9M | $9.5M | $10.2M | $43.0M | $411.0K |
| Liabilities And Stockholders Equity | $8.9M | $14.2M | $10.0M | $2.6M | $231.8M |
| Liabilities | $5.1M | $12.2M | $18.3M | $43.4M | $16.5M |
| Assets Current | $6.3M | $10.2M | $4.3M | $786.0K | $1.5M |
| Assets | $8.9M | $14.2M | $10.0M | $2.6M | $231.8M |
| Amortization Of Debt Discount Premium | $45.0K | $432.0K | $123.0K | ||
| Operating Lease Right Of Use Asset | $1.7M | $2.9M | $4.1M | $199.0K | |
| Operating Lease Liability Noncurrent | $277.0K | $1.8M | $3.0M | $305.0K | |
| Operating Lease Liability Current | $1.4M | $1.2M | $1.0M | $44.0K | |
| Finance Lease Liability Noncurrent | $171.0K | $145.0K | $216.0K | $142.0K | |
| Finance Lease Liability Current | $111.0K | $66.0K | $81.0K | $72.0K | |
| Repayments Of Debt And Capital Lease Obligations | $90.0K | $82.0K | $101.0K | $81.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.0M | $7.6M | $1.6M | -$968.8K | |
| Prepaid Expense And Other Assets Current | $656.0K | $636.0K | $2.4M | $414.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$13.0K | -$28.0K | -$47.0K | -$14.0K | |
| Other Assets Noncurrent | $138.0K | $152.0K | $373.0K | $725.0K | |
| Common Stock Value | $1.0K | $1.0K | $2.0K | ||
| Repayments Of Notes Payable | $200.0K | $300.0K | $1.0M | $38.0K | |
| Unrealized Gain Loss On Investments | $0.00 | ||||
| Remeasurement Of Temporary Equity To Redemption Value | -$2.5M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $1.1M | $864.0K | |||
| Changes In Fair Value Of Debt And Other Liabilities | -$1.2M | $2.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | $1.6M | -$1.6M | |||
| Warrant Liability | $107.0K | $119.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.9M | $1.8M | $6.9M | -$9.8M | -$11.8M | -$14.6M | -$1.1M | -$63.7M | -$55.1M | -$50.4M | -$43.9M | -$39.6M | -$37.6M | -$19.0M | -$58.3K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.6M | $5.4M | $10.8M | $2.1M | $1.1M | $1.4M | $10.4M | $2.3M | $1.1M | $300.0K | $328.8K | $597.5K | $1.2M | $95.0K | $0.00 | |||
| Cash | $1.2M | $0.00 | ||||||||||||||||
| Retained Earnings Accumulated Deficit | -$137.6M | -$132.4M | -$126.7M | -$117.6M | -$112.6M | -$106.8M | -$91.3M | -$12.2M | -$7.9M | -$9.9M | -$9.2M | -$13.2M | -$19.0M | |||||
| Liabilities Current | $5.2M | $5.4M | $5.4M | $11.6M | $13.1M | $15.0M | $10.9M | $8.2M | $6.6M | $1.3M | $373.7K | $386.8K | $47.9K | |||||
| Liabilities And Stockholders Equity | $14.0M | $9.4M | $15.1M | $6.7M | $6.4M | $7.4M | $18.6M | $44.0M | $43.2M | $42.2M | $231.0M | $231.2M | $232.0M | |||||
| Liabilities | $6.8M | $7.3M | $7.8M | $16.5M | $18.2M | $22.0M | $19.7M | $12.8M | $8.2M | $10.4M | $10.1M | $14.5M | $21.0M | |||||
| Assets Current | $11.0M | $6.0M | $11.5M | $2.2M | $1.6M | $1.9M | $11.7M | $795.5K | $268.9K | $479.1K | $759.7K | $1.0M | $2.0M | |||||
| Assets | $14.0M | $9.4M | $15.1M | $6.7M | $6.4M | $7.4M | $18.6M | $44.0M | $43.2M | $42.2M | $231.0M | $231.2M | $232.0M | |||||
| Amortization Of Debt Discount Premium | $16.0K | $16.5K | $201.0K | $0.00 | ||||||||||||||
| Operating Lease Right Of Use Asset | $2.0M | $2.3M | $2.6M | $3.2M | $3.5M | $3.8M | $4.3M | $4.6M | $4.8M | $193.0K | ||||||||
| Operating Lease Liability Noncurrent | $640.0K | $993.0K | $1.5M | $2.2M | $2.5M | $2.8M | $3.2M | $3.5M | $3.8M | $152.0K | ||||||||
| Operating Lease Liability Current | $1.4M | $1.3M | $1.3M | $1.2M | $1.1M | $1.1M | $994.0K | $956.0K | $919.0K | $40.0K | ||||||||
| Finance Lease Liability Noncurrent | $197.0K | $226.0K | $129.0K | $166.0K | $180.0K | $197.0K | $96.0K | $110.0K | $126.0K | $65.0K | ||||||||
| Finance Lease Liability Current | $112.0K | $113.0K | $69.0K | $69.0K | $68.0K | $74.0K | $62.0K | $70.0K | $71.0K | $47.0K | ||||||||
| Repayments Of Debt And Capital Lease Obligations | $17.0K | $23.0K | $19.0K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $970.0K | -$806.0K | $547.0K | -$465.1K | $95.0K | |||||||||||||
| Prepaid Expense And Other Assets Current | $653.0K | $770.0K | $928.0K | $324.0K | $789.0K | $793.0K | $1.5M | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$13.0K | -$13.0K | -$26.0K | -$74.0K | -$27.0K | $11.0K | -$4.0K | |||||||||||
| Other Assets Noncurrent | $140.0K | $40.0K | $144.0K | $217.0K | $227.0K | $506.0K | $148.0K | |||||||||||
| Common Stock Value | $1.0K | $3.0K | $2.0K | $1.0K | $1.0K | $4.0K | $4.0K | $575.00 | ||||||||||
| Repayments Of Notes Payable | $200.0K | $2.0K | ||||||||||||||||
| Unrealized Gain Loss On Investments | $12.8K | $28.0K | $0.00 | $0.00 | $2.3K | $423.00 | $0.00 | |||||||||||
| Remeasurement Of Temporary Equity To Redemption Value | -$307.3K | -$453.8K | -$1.5M | -$160.0K | -$18.8K | -$20.1M | ||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $303.0K | $272.0K | $90.0K | |||||||||||||||
| Changes In Fair Value Of Debt And Other Liabilities | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | ||||||||||||||||||
| Warrant Liability | $186.0K | $96.0K | $81.0K | $163.0K | $524.0K | $647.0K | $623.0K | $3.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$21.3M | -$19.7M | -$27.0M | -$13.2M |
| Net Cash Provided By Used In Financing Activities | $17.5M | $27.4M | $29.0M | $12.1M |
| Increase Decrease In Accounts Payable | -$1.3M | -$628.0K | -$6.2M | $1.6M |
| Net Cash Provided By Used In Investing Activities | -$170.0K | -$16.0K | -$478.0K | -$494.0K |
| Share Based Compensation | $2.1M | $3.0M | $4.8M | $4.5M |
| Payments To Acquire Machinery And Equipment | $120.0K | $16.0K | $585.0K | $428.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $42.0K | -$1.8M | $2.2M | -$170.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.0M | -$1.9M | $1.3M | $1.8M |
| Proceeds From Related Party Debt | $200.0K | $2.6M | ||
| Payments Of Financing Costs | $846.0K | $1.6M | $2.2M | $58.0K |
| Payments To Acquire Restricted Investments | $2.3M | |||
| Proceeds From Stock Options Exercised | $281.0K | $114.0K | ||
| Proceeds From Payments For Security Deposits | $98.0K | -$66.0K | ||
| Increase Decrease In Operating Lease Liability | -$1.4M | -$1.0M | -$628.0K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$6.0K | -$26.0K | ||
| Proceeds From Repayments Of Related Party Debt | $2.0M | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.1M | -$3.8M | -$3.1M | -$465.1K | -$118.8K | |
| Net Cash Provided By Used In Financing Activities | $8.1M | $3.0M | $3.8M | $0.00 | $213.8K | |
| Increase Decrease In Accounts Payable | -$752.0K | $968.0K | $21.0K | -$1.8K | $0.00 | |
| Net Cash Provided By Used In Investing Activities | -$7.0K | -$5.0K | -$137.0K | $0.00 | ||
| Share Based Compensation | $607.0K | $888.0K | $1.4M | |||
| Payments To Acquire Machinery And Equipment | $7.0K | $5.0K | $137.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $317.0K | -$1.6M | $283.0K | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.7M | -$388.0K | $236.0K | |||
| Proceeds From Related Party Debt | $200.0K | $222.5K | $188.8K | |||
| Payments Of Financing Costs | $301.0K | $162.0K | $71.0K | |||
| Payments To Acquire Restricted Investments | $425.9K | $0.00 | $230.0M | |||
| Proceeds From Stock Options Exercised | $181.0K | |||||
| Proceeds From Payments For Security Deposits | ||||||
| Increase Decrease In Operating Lease Liability | -$279.0K | -$238.0K | $36.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | ||||||
| Proceeds From Repayments Of Related Party Debt | $1.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 4.3K | 667.00 | 1.7M | 8.5M | |
| Earnings Per Share Diluted | $-5.95 | $-35.70 | $-17.33 | $2.99 | |
| Weighted Average Number Of Shares Outstanding Basic | 4.3K | 667.00 | 1.7M | 8.5M | |
| Earnings Per Share Basic | $-5.95 | $-35.70 | $-17.33 | $2.99 | |
| Common Stock Shares Outstanding | 7.2M | 1.7M | 3.6M | 8.6M | 23.0M |
| Common Stock Shares Issued | 7.2M | 1.7M | 3.6M | 8.6M | 23.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 330.0M | 330.0M | 330.0M | 330.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 4.9K | 2.9K | 27.1K | 652.00 | 444.00 | 3.6K | 1.4M | 878.0K | 8.7M | 8.6M | ||
| Earnings Per Share Diluted | $-2.21 | $-1.99 | $-0.18 | $-7.75 | $-16.75 | $-2.03 | $-1.41 | $-14.24 | $-0.75 | $-0.63 | ||
| Weighted Average Number Of Shares Outstanding Basic | 4.9K | 2.9K | 27.1K | 652.00 | 444.00 | 3.6K | 1.4M | 878.0K | 8.7M | 8.6M | ||
| Earnings Per Share Basic | $-2.21 | $-1.99 | $-0.18 | $-7.75 | $-16.75 | $-2.03 | $-1.41 | $-14.24 | $-0.75 | $-0.63 | ||
| Common Stock Shares Outstanding | 6.9M | 2.9M | 31.8M | 9.3M | 6.5M | 35.7M | 35.4M | 4.1M | 23.0M | 23.0M | ||
| Common Stock Shares Issued | 6.9M | 2.9M | 31.8M | 9.3M | 6.5M | 35.7M | 35.4M | 4.1M | 23.0M | 23.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Authorized | 330.0M | 330.0M | 330.0M | 330.0M | 330.0M | 330.0M | 330.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Additional Paid In Capital | $145.4M | $123.3M | $91.4M | $19.9M | $0.00 |
| Depreciation | $402.0K | $392.0K | $260.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.1M | $3.0M | $4.8M | $4.5M | |
| Stock Issued During Period Shares New Issues | 175.0K | 718.6K | 109.7K | ||
| Interest Paid Net | $1.3M | $140.0K | $404.0K | $35.0K | |
| Grant Income | $50.0K | $181.0K | $2.9M | ||
| Gain Loss Due To Change In Fair Value Of Forward Purchase Units | $195.0K | ||||
| Fair Value Adjustment Of Warrants | -$6.7M | ||||
| Stock Issued During Period Value Stock Options Exercised | $281.0K | $114.0K | |||
| Machinery And Equipment Gross | $869.0K | $1.3M | $887.0K | ||
| Stock Issued During Period Value Issued For Services | $369.0K | $205.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $144.5M | $134.2M | $133.7M | $107.4M | $100.8M | $92.2M | $90.2M | $182.7K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Depreciation | $91.0K | $100.0K | $100.0K | $102.0K | $100.0K | $100.0K | $93.0K | $100.0K | ||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $529.0K | $522.0K | $607.0K | $691.0K | $751.0K | $888.0K | $1.1M | $1.1M | $1.4M | $1.1M | $936.0K | |||
| Stock Issued During Period Shares New Issues | 7.5M | 2.7M | 5.0K | |||||||||||
| Interest Paid Net | $639.0K | $24.0K | $12.0K | |||||||||||
| Grant Income | $50.0K | $181.0K | $693.0K | $889.0K | $691.0K | |||||||||
| Gain Loss Due To Change In Fair Value Of Forward Purchase Units | -$1.8M | -$554.4K | $210.4K | $333.0K | -$122.0K | -$11.8K | $0.00 | |||||||
| Fair Value Adjustment Of Warrants | $1.3M | -$88.5K | -$460.0K | -$4.0M | -$2.1M | -$283.0K | $0.00 | |||||||
| Stock Issued During Period Value Stock Options Exercised | $50.0K | $50.0K | $181.0K | $114.0K | ||||||||||
| Machinery And Equipment Gross | $982.0K | $1.1M | $1.2M | $1.1M | ||||||||||
| Stock Issued During Period Value Issued For Services | $29.0K | $13.0K | $158.0K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.